# Observational Neuroendocrine Tumors studies: 30 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials that are observational for Neuroendocrine Tumors that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Neuroendocrine Tumors studies: 30 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/neuroendocrine-tumors

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 30
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07939113 | Real-World Effectiveness of Cabozantinib in Advanced Neuroendocrine Tumors: A Retrospective Multicenter Study Using the GTE-RENATEN... | Hospices Civils de Lyon | Observational | Not yet recruiting | Advanced Neuroendocrine Carcinoma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939113) |
| October 29, 2026 | NCT07903532 | Multicenter Study for External Validation of the TB-NET Score | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Observational | Recruiting | Tumor Burden, Neuroendocrine (NE) Tumors | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903532) |
| June 2, 2026 | NCT07621146 | A Comparison of \[68Ga\]DOTATATE and \[18F\]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies | British Columbia Cancer Agency | Observational | Not yet recruiting | Neuroendocrine Tumors, NET, Pheochromocytoma/Paraganglioma, SSTR-expressing Tumors, Medullary Thyroid Carcinoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621146) |
| March 11, 2026 | NCT07463872 | Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data | Huazhong University of Science and Technology | Observational | Recruiting | Pancreatic Cystic Lesion, Mucinous Cystadenoma of Pancreas, Intraductal Papillary Mucinous Neoplasm of Pancreas... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07463872) |
| March 4, 2026 | NCT07450287 | CardioNETPOL National Registry of Carcinoid Heart Disease | National Institute of Cardiology, Warsaw, Poland | Observational | Not yet recruiting | Carcinoid Heart Disease, Neuroendocrine Tumors, Carcinoid Syndrome, Valvular Heart Disease Patients | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07450287) |
| January 2, 2026 | NCT07314164 | Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment | Ipsen | Observational | Recruiting | Neuroendocrine Tumors | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07314164) |
| December 24, 2025 | NCT07302100 | Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital | University Hospital, Strasbourg, France | Observational | Recruiting | Gastroenteropancreatic Neuroendocrine Tumor | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07302100) |
| December 2, 2025 | NCT07258810 | Evaluation of Tolerance and Quality of Life in Patients With Neuroendocrine Tumors Treated With Oral Anti-Tumor Drugs Within a Therapeutic... | Hospices Civils de Lyon | Observational | Not yet recruiting | Neuroendocrine (NE) Tumors, Oral Anti-Tumor Drugs, Therapeutic Education Program | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07258810) |
| August 3, 2025 | NCT07102056 | 18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms | First Affiliated Hospital of Zhejiang University | Observational | Not yet recruiting | Neuroendocrine Tumors | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07102056) |
| April 22, 2025 | NCT06937112 | 18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis | Nanjing First Hospital, Nanjing Medical University | Observational | Recruiting | Lung Cancers, Pancreatic Cancer, Neuroendocrine Tumors, Thyroid Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06937112) |
| July 26, 2024 | NCT06523582 | Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients | Universidad Nacional Autonoma de Mexico | Observational | Recruiting | Neuroendocrine Neoplasm, Neuroendocrine Neoplasm of Gastrointestinal Tract, Neuroendocrine Neoplasm of Lung, Thymic... | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06523582) |
| May 28, 2024 | NCT06430021 | Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation | Centre Hospitalier Universitaire Dijon | Observational | Recruiting | Neuroendocrine Tumors, MEN1 Mutation | 297 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06430021) |
| April 10, 2024 | NCT06356467 | Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs | IRCCS San Raffaele | Observational | Recruiting | Neuroendocrine Tumors, GEP-NET | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06356467) |
| April 3, 2024 | NCT06344507 | Iconographic Registry of Pancreatobiliary Endoscopy Procedures | IRCCS San Raffaele | Observational | Recruiting | Pancreas Neoplasm, Cancer of Pancreas, Pancreatitis, Neuroendocrine Tumors | 12,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06344507) |
| March 29, 2024 | NCT06337760 | YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. | European Institute of Oncology | Observational | Recruiting | Neuroendocrine Neoplasm, Adenocarcinoma | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06337760) |
| March 8, 2024 | NCT06300216 | A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors | Qilu Hospital of Shandong University | Observational | Not yet recruiting | Neuroendocrine Tumors | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06300216) |
| February 5, 2024 | NCT06242119 | Clinical Application of the J-PET Scanner Prototype | Jagiellonian University | Observational | Recruiting | Prostate Cancer, Prostatic Hyperplasia, Prostatic Neoplasms, Prostate Cancer Metastatic, Neuroendocrine Tumors... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06242119) |
| September 21, 2023 | NCT06043193 | Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor... | Hospices Civils de Lyon | Observational | Recruiting | Metastatic Neuroendocrine Tumour | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06043193) |
| August 29, 2023 | NCT06015802 | Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine... | Sun Yat-sen University | Observational | Recruiting | Pituitary Adenoma, Neuroendocrine Tumors | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06015802) |
| April 7, 2023 | NCT05804331 | The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study | Western Sydney Local Health District | Observational | Recruiting | Cancer of Stomach, Oesophageal Cancer, Gastric Cancer, Gastric Adenocarcinoma, GI Cancer, GIST, Neuroendocrine Tumors... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05804331) |
| January 5, 2023 | NCT05673031 | 68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors | Alberta Health services | Observational | Recruiting | Neuroendocrine Tumors (NET) | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05673031) |
| February 14, 2022 | NCT05237934 | Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC) | National Cancer Institute (NCI) | Observational | Recruiting | Neuroendocrine Tumors, Carcinoma, Neuroendocrine | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05237934) |
| December 16, 2021 | NCT05160480 | A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG | University of California, Davis | Observational | Recruiting | Prostate Cancer, Breast Cancer, Neuroendocrine Tumors | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05160480) |
| July 2, 2021 | NCT04949282 | Spanish Series of Patients Treated With the Radionuclide Lutetium177 | Sociedad Española de Medicina Nuclear e Imagen Molecular | Observational | Recruiting | Neuroendocrine Tumors, Intestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Neuroectodermal Tumors... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04949282) |
| March 9, 2021 | NCT04788927 | Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study | Copenhagen University Hospital, Rigshospitalet | Observational | Not yet recruiting | Paraganglioma, Pheochromocytoma, Genetic Predisposition to Disease, Pathology, Somatic Mutation, Head and Neck Cancer... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04788927) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Hospices Civils de Lyon | 3 |
| IRCCS San Raffaele | 2 |
| Nanjing First Hospital, Nanjing Medical University | 1 |
| Universidad Nacional Autonoma de Mexico | 1 |
| Centre Hospitalier Universitaire Dijon | 1 |
| British Columbia Cancer Agency | 1 |
| Copenhagen University Hospital, Rigshospitalet | 1 |
| Sociedad Española de Medicina Nuclear e Imagen Molecular | 1 |
| Jagiellonian University | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| University of Roma La Sapienza | 1 |
| Western Sydney Local Health District | 1 |
| Sun Yat-sen University | 1 |
| European Institute of Oncology | 1 |
| University of Nebraska | 1 |
| National Cancer Institute (NCI) | 1 |
| National Institute of Cardiology, Warsaw, Poland | 1 |
| Children's Oncology Group | 1 |
| Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 1 |
| [Ipsen](https://specstream.ai/data/clinical-trials/company/ipsen) | 1 |
| Massive Bio, Inc. | 1 |
| University of California, Davis | 1 |
| University Hospital, Strasbourg, France | 1 |
| Huazhong University of Science and Technology | 1 |
| Qilu Hospital of Shandong University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| France | 6 |
| Italy | 5 |
| China | 4 |
| Canada | 3 |
| Poland | 3 |
| Spain | 2 |
| Australia | 2 |
| Puerto Rico | 2 |
| Germany | 2 |
| Mexico | 1 |
| Denmark | 1 |
| New Zealand | 1 |
| Saudi Arabia | 1 |
| Brazil | 1 |
| Sweden | 1 |
| Turkey (Türkiye) | 1 |
| Austria | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Engineering firms in the United States](https://specstream.ai/data/businesses/engineering-firms/united-states)
- [B2B advertising and marketing companies in the United States](https://specstream.ai/data/businesses/b2b-advertising-and-marketing-companies/united-states)
- [Restaurant wholesale companies in the United States](https://specstream.ai/data/businesses/restaurant-wholesale-companies/united-states)
- [IP and internet law firms in the United States](https://specstream.ai/data/businesses/ip-and-internet-law-firms/united-states)
- [Corporate gift suppliers in the United States](https://specstream.ai/data/businesses/corporate-gift-suppliers/united-states)
- [Waterproofing contractors in the United States](https://specstream.ai/data/businesses/waterproofing-contractors/united-states)
